173 related articles for article (PubMed ID: 32738352)
1. Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study.
Fabbri C; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; De Ronchi D; Riva MA; Lewis CM; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110050. PubMed ID: 32738352
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposing.
Fabbri C; Pain O; Hagenaars SP; Lewis CM; Serretti A
Neuropsychopharmacology; 2021 Sep; 46(10):1821-1829. PubMed ID: 34158615
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel.
Sharman Moser S; Chodick G; Gelerstein S; Barit Ben David N; Shalev V; Stein-Reisner O
BMC Psychiatry; 2022 Aug; 22(1):541. PubMed ID: 35948895
[TBL] [Abstract][Full Text] [Related]
4. Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database.
Kubitz N; Mehra M; Potluri RC; Garg N; Cossrow N
PLoS One; 2013; 8(10):e76882. PubMed ID: 24204694
[TBL] [Abstract][Full Text] [Related]
5. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
[TBL] [Abstract][Full Text] [Related]
6. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
[TBL] [Abstract][Full Text] [Related]
7. Overview of treatment-resistant depression.
Li CT
Prog Brain Res; 2023; 278():1-23. PubMed ID: 37414489
[TBL] [Abstract][Full Text] [Related]
8. Understanding treatment-resistant depression using "omics" techniques: A systematic review.
Amasi-Hartoonian N; Pariante CM; Cattaneo A; Sforzini L
J Affect Disord; 2022 Dec; 318():423-455. PubMed ID: 36103934
[TBL] [Abstract][Full Text] [Related]
9. Can Machine Learning help us in dealing with treatment resistant depression? A review.
Pigoni A; Delvecchio G; Madonna D; Bressi C; Soares J; Brambilla P
J Affect Disord; 2019 Dec; 259():21-26. PubMed ID: 31437696
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder.
Gronemann FH; Petersen J; Alulis S; Jensen KJ; Riise J; Ankarfeldt MZ; Solem EJ; Bødker N; Osler M
J Affect Disord; 2021 May; 287():204-213. PubMed ID: 33799039
[TBL] [Abstract][Full Text] [Related]
11. Ketamine: Future Treatment For Unresponsive Depression?
Frere M; Tepper J
Ir Med J; 2016 Sep; 109(8):453. PubMed ID: 28124853
[TBL] [Abstract][Full Text] [Related]
12. A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.
McCarthy MJ; Chen Y; Demodena A; Leckband SG; Fischer E; Golshan S; Suppes T; Kelsoe JR
J Psychopharmacol; 2021 Aug; 35(8):992-1002. PubMed ID: 33938307
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug-Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression.
Zhdanava M; Karkare S; Pilon D; Joshi K; Rossi C; Morrison L; Sheehan J; Lefebvre P; Lopena O; Citrome L
Adv Ther; 2021 Sep; 38(9):4900-4916. PubMed ID: 34368919
[TBL] [Abstract][Full Text] [Related]
14. Use of Ketamine in Elderly Patients with Treatment-Resistant Depression.
Medeiros da Frota Ribeiro C; Riva-Posse P
Curr Psychiatry Rep; 2017 Nov; 19(12):107. PubMed ID: 29138992
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological approaches to the challenge of treatment-resistant depression.
Ionescu DF; Rosenbaum JF; Alpert JE
Dialogues Clin Neurosci; 2015 Jun; 17(2):111-26. PubMed ID: 26246787
[TBL] [Abstract][Full Text] [Related]
16. A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping.
Fabbri C; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Uher R; Lewis CM; Serretti A
Transl Psychiatry; 2020 Feb; 10(1):50. PubMed ID: 32066715
[TBL] [Abstract][Full Text] [Related]
17. Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review.
Rosenblat JD; McIntyre RS; Alves GS; Fountoulakis KN; Carvalho AF
Curr Neuropharmacol; 2015; 13(5):636-55. PubMed ID: 26467412
[TBL] [Abstract][Full Text] [Related]
18. Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review.
Caldiroli A; Capuzzi E; Tagliabue I; Capellazzi M; Marcatili M; Mucci F; Colmegna F; Clerici M; Buoli M; Dakanalis A
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884874
[TBL] [Abstract][Full Text] [Related]
19. Repeated intravenous infusions of ketamine: Neurocognition in patients with anxious and nonanxious treatment-resistant depression.
Liu W; Zhou Y; Zheng W; Wang C; Zhan Y; Lan X; Zhang B; Li H; Chen L; Ning Y
J Affect Disord; 2019 Dec; 259():1-6. PubMed ID: 31430662
[TBL] [Abstract][Full Text] [Related]
20. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
